loadpatents
name:-0.029174089431763
name:-0.024640083312988
name:-0.013445854187012
Collins; Michael Raymond Patent Filings

Collins; Michael Raymond

Patent Applications and Registrations

Patent applications and USPTO patent grants for Collins; Michael Raymond.The latest application filed is for "cycloalkyl-linked diheterocycle derivatives".

Company Profile
11.18.22
  • Collins; Michael Raymond - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cycloalkyl-linked diheterocycle derivatives
Grant 10,676,471 - Burns , et al.
2020-06-09
Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents
Grant 10,662,204 - Planken , et al.
2020-05-26
Tetrahydroquinazoline derivatives useful as anticancer agents
Grant 10,590,115 - Planken , et al.
2020-03-17
Substituted dihydroisoquinolinone compounds
Grant 10,570,121 - Collins , et al. Feb
2020-02-25
3-indol substituted derivatives, pharmaceutical compositions and methods for use
Grant 10,544,095 - Ninkovic , et al. Ja
2020-01-28
Cycloalkyl-Linked Diheterocycle Derivatives
App 20190270737 - Burns; Aaron Craig ;   et al.
2019-09-05
Tetrahydroquinazoline Derivatives Useful as Anticancer Agents
App 20190248767 - PLANKEN; Simon ;   et al.
2019-08-15
Substituted Quinazoline and Pyridopyrimidine Derivatives Useful as Anticancer Agents
App 20190233440 - PLANKEN; Simon ;   et al.
2019-08-01
Substituted Dihydroisoquinolinone Compounds
App 20190040047 - Collins; Michael Raymond ;   et al.
2019-02-07
Cycloalkyl-Linked Diheterocycle Derivatives
App 20190040055 - Burns; Aaron Craig ;   et al.
2019-02-07
Cycloalkyl-linked diheterocycle derivatives
Grant 10,125,130 - Burns , et al. November 13, 2
2018-11-13
Novel 3-indol Substituted Derivatives, Pharmaceutical Compositions And Methods For Use
App 20180222862 - Ninkovic; Sacha ;   et al.
2018-08-09
Cycloalkyl-Linked Diheterocycle Derivatives
App 20180148441 - BURNS; Aaron Craig ;   et al.
2018-05-31
3-indol substituted derivatives, pharmaceutical compositions and methods for use
Grant 9,873,690 - Ninkovic , et al. January 23, 2
2018-01-23
Substituted Dihydroisoquinolinone Compounds
App 20170298048 - Collins; Michael Raymond ;   et al.
2017-10-19
Axl inhibitors
Grant 9,593,097 - Johnson , et al. March 14, 2
2017-03-14
Cycloalkyl-Linked Diheterocycle Derivatives
App 20170050958 - BURNS; Aaron Craig ;   et al.
2017-02-23
Substituted Dihydroisoquinolinone Compounds
App 20160376254 - COLLINS; Michael Raymond ;   et al.
2016-12-29
Novel 3-indol Substituted Derivatives, Pharmaceutical Compositions And Methods For Use
App 20160272628 - Ninkovic; Sacha ;   et al.
2016-09-22
Axl Inhibitors
App 20160176850 - Johnson; Ted William ;   et al.
2016-06-23
Substituted Dihydroisoquinolinone Compounds
App 20150361067 - Collins; Michael Raymond ;   et al.
2015-12-17
Macrocyclic derivatives for the treatment of diseases
Grant 9,133,215 - Bailey , et al. September 15, 2
2015-09-15
Macrocyclic Derivatives For The Treatment Of Diseases
App 20140135339 - Bailey; Simon ;   et al.
2014-05-15
Macrocyclic derivatives for the treatment of diseases
Grant 8,680,111 - Bailey , et al. March 25, 2
2014-03-25
Macrocyclic Derivatives For The Treatment Of Diseases
App 20130252961 - BAILEY; Simon ;   et al.
2013-09-26
6 substituted 2-heterocyclylamino pyrazine compounds as CHK-1 inhibitors
Grant 8,518,952 - Braganza , et al. August 27, 2
2013-08-27
6 Substituted 2- Heterocyclylamino Pyrazine Compounds As Chk-1 Inhibitors
App 20110144084 - Braganza; John Frederick ;   et al.
2011-06-16
Inhibitors Of Hepatitis C Virus Protease, And Compositions And Treatments Using The Same
App 20070249637 - Collins; Michael Raymond ;   et al.
2007-10-25
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Grant 7,141,587 - Kania , et al. November 28, 2
2006-11-28
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
App 20050124662 - Kania, Robert Steven ;   et al.
2005-06-09
Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
Grant 6,891,044 - Kania , et al. May 10, 2
2005-05-10
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Grant 6,884,890 - Kania , et al. April 26, 2
2005-04-26
Indazole Compounds And Pharmaceutical Compositions For Inhibiting Protein Kinases, And Methods For Their Use
App 20040220248 - Kania, Robert Steven ;   et al.
2004-11-04
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
App 20040171634 - Kania, Robert Steven ;   et al.
2004-09-02
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
App 20040092747 - Bender, Steven Lee ;   et al.
2004-05-13
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Grant 6,635,641 - Bender , et al. October 21, 2
2003-10-21
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Grant 6,534,524 - Kania , et al. March 18, 2
2003-03-18
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Grant 6,531,491 - Kania , et al. March 11, 2
2003-03-11
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
App 20020103203 - Bender, Steven Lee ;   et al.
2002-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed